ArticleOcular oncology and pathology2019
Uveal Melanoma in Ireland.
Article in Ocular oncology and pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Efficacy and safety of proton radiotherapy in treating choroidal melanoma: a systematic review and meta-analysis.Radiation oncology (London, England) · 2025Pooled it
- Global Incidence and Trend of Uveal Melanoma from 1943-2015: A Meta-Analysis.Asian Pacific journal of cancer prevention : APJCP · 2022Pooled it
- Recent advances in the molecular genetic mechanisms and immune microenvironment of uveal melanoma.Melanoma research · 2026Review
- Paediatric uveal melanoma in Ireland 2010 - 2024: incidence, clinical features, management, and outcomes.Eye (London, England) · 2026Article
- Artificial Intelligence in the Detection and Risk Stratification of Choroidal Melanoma: A Critical Comparative Synthesis and Future Directions.Healthcare (Basel, Switzerland) · 2025Review
- Longitudinal nationwide analysis of uveal melanoma in the United States1995-2018.International journal of clinical oncology · 2025Article
- Identification of two distinct uveal melanoma subtypes based on the immune cell infiltration of the primary tumour.Cancer immunology, immunotherapy : CII · 2025Article
- Precision prognostic model for uveal melanoma: nomogram prediction and comparison with AJCC system.Discover oncology · 2025Article
- Current Treatment of Uveal Melanoma.Cancers · 2025Review
- Article
- Uveal melanoma in the Iranian population: two decades of patient management in a tertiary eye center.International journal of retina and vitreous · 2024Article
- Article
- Incidence, risk factors and outcomes of cataract surgery after plaque brachytherapy for posterior uveal melanoma.Heliyon · 2024Article
- Ocular oncology service during the COVID-19 outbreak: uveal melanoma characteristics presenting in 2019 compared to 2020.Irish journal of medical science · 2023Article
- Comprehensive causes of death in uveal melanoma: mortality in 1530 consecutively diagnosed patients followed until death.JNCI cancer spectrum · 2023Article
- Worldwide Incidence of Ocular Melanoma and Correlation With Pigmentation-Related Risk Factors.Investigative ophthalmology & visual science · 2023Article
- Incidence and survival of uveal melanoma in Northern Ireland: how incomplete data can skew results in rare cancers.Eye (London, England) · 2023Article
- The effects of exposure to solar radiation on human health.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2023Article
- Sex Differences in the Treatment of Uveal Melanoma in a Group of 1336 Patients.Journal of personalized medicine · 2023Article
- Clinical determinants of long-term survival in metastatic uveal melanoma.Cancer immunology, immunotherapy : CII · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo report the clinical features and epidemiology of uveal melanoma in Ireland.
methodsThis was an observational study of 253 patients with a new diagnosis of uveal melanoma between June 2010 and December 2015. Main outcome measures included demographics, clinical features, age-adjusted incidence, relative survival, overall survival, and distant metastases-free survival.
resultsThe mean patient age was 61.7 years. Tumour location was choroidal in 82%, ciliochoroidal in 9%, iridociliary in 2%, and iris in 7%. Treatment modalities included brachytherapy (ruthenium-106 and iodine-125 [64%]), enucleation (27%), and proton beam radiation (8%). The mean age-adjusted incidence of uveal melanoma in Ireland from 2010 to 2015 was 9.5 per million of the population (95% confidence interval [CI]: 8.4-10.7). Four-year relative survival was 81.3% (95% CI: 72.8-87.3). Four-year overall survival was 84% (95% CI: 78-90) and 4-year distant metastases-free survival was 79% (95% CI: 73-86).
conclusionBased on this data, the incidence of uveal melanoma in Ireland is high when compared with other reported incidence rates in Europe and worldwide. Relative and observed survival were in keeping with other reported European survival rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.